FABP4 and pulmonary fibrosis: Immunohistochemical staining showed that LIRI increased TGF‐β expression in AAV‐shCtl mice, while AAV‐shFabp4 treatment significantly reduced TGF‐β levels (Figure 6D,G), indicating that FABP4 knockdown attenuates pulmonary fibrosis.